Ultragenyx Pharmaceutical | RARE - Capitaux Propres Et Réserves

Prix De L'Action
19.87
Variation Quotidienne
-0.55 -2.69%
Mensuellement
-11.73%
Annuel
-49.29%
Q1 Prévisions
19.27




Capitaux Propres Et Réserves Changement Date
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Immunic USD 10.5M 23.41M 2025-09
Insmed USD 738.98M 206.6M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Kyowa Hakko Kirin JPY 893.33B 47.21B 2025-12
MacroGenics USD 55.59M 11.41M 2025-12
Moderna USD 8.65B 680M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12
Xoma USD 87.94M 15.5M 2025-09